Elsevier

Molecular Brain Research

Volume 69, Issue 1, 21 May 1999, Pages 135-143
Molecular Brain Research

Research report
Tumor necrosis factor alpha expression produces increased blood–brain barrier permeability following temporary focal cerebral ischemia in mice

https://doi.org/10.1016/S0169-328X(99)00007-8Get rights and content

Abstract

Alteration of blood–brain barrier (BBB) function occurs in both permanent and temporary cerebral ischemia. Studies in vivo and in vitro have shown that tumor necrosis factor-alpha (TNFα) is involved in changes of BBB permeability. However, the relationship between TNFα expression and BBB disruption during reperfusion is unclear. The aim of this study is to find the cell source of TNFα and to determine the relationship between TNFα expression and BBB disruption following temporary focal cerebral ischemia in mice. Adult CD-1 mice received 1 h middle cerebral artery occlusion (MCAO) followed by 2 h, 6 h, 12 h, 24 h, and 48 h of reperfusion. MCAO was achieved using an intraluminal suture technique and reperfusion was performed by the suture withdrawal. Neutralizing monoclonal anti-mouse TNFα antibody was administrated intraventricularly immediately after reperfusion. TNFα expression was determined by double labeling immunohistochemistry. BBB permeability was determined by albumin immunostaining. TNFα immunoreactivity (IR) was observed in the ipsilateral hemisphere from 1 h MCAO with 2 h reperfusion. TNFα positive cells included neurons, astrocytes, and ependymal cells. BBB disruption was detected beginning at 6 h reperfusion but was not present at 2 h of reperfusion. The areas of BBB disruption were significantly enlarged at 12 h reperfusion and plateaued at 24 h to 48 h reperfusion. BBB disruptions were significantly attenuated in the anti-TNFα antibody treated mice (p<0.05). Our results demonstrate that TNFα IR existed in neurons, astrocytes, and ependymal cells during reperfusion. TNFα IR following temporary focal cerebral ischemia precedes increased BBB permeability. Treatment with TNFα antibody reduces BBB disruption, suggesting TNFα may be an important mediator in altering BBB permeability during reperfusion.

Introduction

The blood–brain barrier (BBB) functions to eliminate the entry of macromolecules, microbial pathogens, and circulating leukocytes into the central nervous system (CNS). BBB breakdown occurs following postischemic reperfusion in the brain 8, 10, 26. The integrity of the BBB may play an important role in the subsequent pathophysiology since BBB disruption relates closely to brain edema formation and cerebral infarction following postischemic reperfusion [5]. However, the mechanism of BBB disruption during postischemic reperfusion is unclear.

Tumor necrosis factor-alpha (TNFα), a 17 kD pleiotropic cytokine, appears to be involved in BBB disruption in brain injury [11]. In patients with bacterial meningitis, intrathecal TNFα levels correlate with the albumin quotient (Qalb), which is the best chemical indicator of barrier damage 28, 32. In patients with active multiple sclerosis, only those with detectable TNFα showed signs of BBB damage [29]. Administration of TNFα into the cerebrospinal fluid (CSF) of newborn pigs induced an extravasation of sodium fluorescein in different regions of the brain parenchyma [22]. Using a similar method in rats, intracisternal administration of TNFα causes circulating albumin to enter into the CSF [17]. In vitro studies have shown that exposure of differentiated brain capillary endothelial cells co-cultured with astrocytes to high concentrations of TNFα leads to a delayed increase in sucrose permeability and a selective reorganization of F-actin filaments [9].

TNFα levels in brain tissue, plasma, and CSF are elevated in several CNS disorders including cerebral ischemia 20, 21, 23, 33. The expression of TNFα mRNA increases from 30 min to 5 days after focal cerebral ischemia in the rat [34]. Early TNFα mRNA and immunohistochemical expression have been identified in neurons, microglia, and astrocytes following cerebral ischemia in both rats and mice 6, 20, 33, 34. Recent studies demonstrate that TNFα exacerbates focal ischemic brain injury and blocking endogenous TNF seems neuroprotective [4].

TNFα may be an important mediator in altering BBB permeability during postischemic reperfusion, but how postischemic reperfusion induces BBB disruption is still unknown. The purposes of this study are (1) to find the cellular source of TNFα following mouse temporary middle cerebral artery occlusion (MCAO), and (2) to demonstrate the relationship between TNFα overexpression and BBB disruption.

Section snippets

Materials and methods

Procedures using laboratory animals were approved by the institutional animal care and use committee. Eighty-eight mice (N=6 to 8 in each group) were subjected to three experiments. In the double labeling immunofluorescence experiment, five groups of mice (N=6) were subjected to 1 h MCAO followed by 2, 6, 12, 24 and 48 h reperfusion. A control group of mice (N=6) received the surgical procedure without MCAO. In the albumin immunostaining experiment, six groups (0, 2, 6, 12, 24 and 48 h) of mice

Results

Physiological parameters The physiological parameters including blood pressure, blood gases, and body temperature were in the normal range during ischemia in the experimental mice. There were no significant differences in the physiological parameters between neutralizing antibody treated and control groups and they are all in the normal ranges (p>0.05, data not shown here).

CBF at the ischemic core region was reduced to 14±2% and 12±3% of the baseline 5 min after occlusion in the control group

Discussion

An alteration of BBB permeability following cerebral ischemia and reperfusion may be an important factor in the evolution of ischemic and reperfusion brain damage, especially in secondary damage [2]. BBB disruption after postischemic reperfusion depends upon the degree and the duration of ischemia [12]. Using the rat four vessel occlusion model, several investigators reported that 30 min occlusion followed by 1 or 3 h reperfusion resulted in BBB disruption and brain edema formation 10, 26.

Acknowledgements

These studies were supported by grants NS35089 (GYY) and NS23870 (ALB) from the National Institutes of Health. The authors thank Dr. Richard F. Keep for helpful discussion and Ms. Kathleen Donahoe for editorial assistance.

References (39)

  • W.M. Clark et al.

    Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule

    J. Neurosurg.

    (1991)
  • D.J. Cole et al.

    Time- and pressure-dependent changes in blood–brain barrier permeability after temporary middle cerebral artery occlusion in rats

    Acta Neuropathol. (Berl.)

    (1991)
  • M.A. Deli et al.

    Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin

    J. Neurosci. Res.

    (1995)
  • J. Dobbin et al.

    Transient blood–brain barrier permeability following profound temporary global ischaemia: an experimental study using 14C-AIB

    J. Cereb. Blood Flow Metab.

    (1989)
  • G.Z. Feuerstein et al.

    Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha

    Cerebrovasc. Brain Metab. Rev.

    (1994)
  • J.M. Hallenbeck et al.

    Background review and current concepts of reperfusion injury

    Arch. Neurol.

    (1990)
  • J.M. Harlan

    Neutrophil-mediated vascular injury

    Acta Med. Scand., Suppl.

    (1987)
  • R.C. Janzer et al.

    Astrocytes induce blood–brain barrier characteristics in cerebral endothelial cells

    Nature

    (1987)
  • J. Kawagoe et al.

    Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood–brain barrier in rats: a quantitative study

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1992)
  • Cited by (141)

    • Blood brain barrier-on-a-chip to model neurological diseases

      2023, Journal of Drug Delivery Science and Technology
    • Methylene blue post-treatment improves hypoxia-ischemic recovery in a neonatal rat model

      2020, Neurochemistry International
      Citation Excerpt :

      Knockout of IL-1β or blocking IL-1β receptor after ischemia was shown to reduce BBB disruption and brain infarct volume (Betz et al., 1995; Boutin et al., 2001). Similar to IL-1β, another potent cytokine TNF-α which is rapidly elevated after ischemic brain injury, can also increase BBB permeability, while TNF-α neutralization is able to attenuate the BBB breakdown (Yang et al., 1999). Here, we demonstrated that MB treatment strongly reduced BBB disruption in neonatal HI rat brains, as evidenced by decreased NaF and Evans Blue vascular infiltration.

    • The Effects of Mouse Recombinant Resistin on mRNA Expression of Proinflammatory and Anti-Inflammatory Cytokines and Heat Shock Protein-70 in Experimental Stroke Model

      2018, Journal of Stroke and Cerebrovascular Diseases
      Citation Excerpt :

      This finding is in agreement with the pattern of mRNA expression of proinflammatory cytokines. According to recent studies, treatment with TNF-α antibody reduces BBB disruption.31 A study suggested that a slight increase in the level of cytokine expression in the initial stage of onset of ischemia might be effective in the development of the infarct region.19

    View all citing articles on Scopus
    View full text